{
    "clinical_study": {
        "@rank": "158143", 
        "arm_group": [
            {
                "arm_group_label": "Early stage abdominal drainage", 
                "arm_group_type": "Other", 
                "description": "SAP patients who matches one of the following criteria:1\uff0eIntravesical pressure\u226520cmH2O or 2.CT images:acute peripancreatic liquid collection should have early stage abdominal drainage immediately;"
            }, 
            {
                "arm_group_label": "Late stage abdominal drainage", 
                "arm_group_type": "Other", 
                "description": "Despite that it matches one of the cirteria as the study group:1\uff0eIntravesical pressure\u226520cmH2O or 2\uff0eCT images:acute peripancreatic liquid collection, the patients continue acquire prearranged integrative treatment and will not accept early stage abdominal drainage until any of the followings emerge:1.Intra-abdominal apartment syndrome; 2. Pancreatic pseudocyst;3. Pancreatic or peripancreatic necrosis;"
            }
        ], 
        "brief_summary": {
            "textblock": "This study aims to standardized the process of mini-invasive abdominal draniage of SAP in\n      early stage.To determine the indications and occasion."
        }, 
        "brief_title": "Effects of Early Stage Mini-invasive Abdominal Drainage on Complications and Prognosis of SAP", 
        "completion_date": {
            "#text": "August 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Pancreatitis", 
        "condition_browse": {
            "mesh_term": "Pancreatitis"
        }, 
        "detailed_description": {
            "textblock": "Pancreatitis associated ascetic fluids(PAAF) gather with the beginning of SAP and induced\n      IAP(intra-abdominal pressure) increasement.With an excess of 12mmHg ,IAP presents as\n      IAH(intra-abdominal hypertension) and when a \u226520mmHg IAP accompanied with at least one\n      organ's dysfunction it is ACS(abdominal compartment syndrome).Previous recommended theraphy\n      of ACS is laparotomy.However,with inherited advantages such as ease-to-operate and minimal\n      invassiveness, early stage mini-invasive abdominal drainage therapies , for example,\n      percutaneous catheter drainage(PCD) instructed by ultrasound or CT ,have shown a promised\n      future in recent years. It is reported that patients acquired PCD decreased  81% in\n      operation rate compared to those who did not and had lower mortality rate. Whereas, the\n      operation flow of early stage mini-invasive abdominal drainage remains controversial, and\n      whose validity calls for evidence from large-scale clinical trials."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        1.Diagnosis of pancreatitis 2.Onset of abdominal pain within 72h 3.Moderate severe or\n        severe AP according to Atlanta criteria revisited in 2012 4.Intravesical pressure\u226520cmH2O\n        4.CT images:acute peripancreatic liquid collection\n\n        -\n\n        Exclusion Criteria:\n\n        1.Pregnancy 2.Heart function: NYHA >II 3.Pacemaker implantation 4.COPD 5.CKD\n        6.Pre-existing disease with life expectancy < 3 months 7.CT images:No acute peripancreatic\n        liquid collection 8.Intravesical pressure>25cmH2O 9.At least one organ'S newly emerged\n        dysfunction\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02002793", 
            "org_study_id": "SAP bundle-abdominal drainage"
        }, 
        "intervention": [
            {
                "arm_group_label": "Early stage abdominal drainage", 
                "description": "Ultrasound/CT/GUS guided abdominocentesis and drainage with single-chamber deep venous catheters shoule be implemented and the catheter should be removed when abdominal drainage flow\u2264100ml in two successive days;", 
                "intervention_name": "Early stage abdominal drainage", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Late stage abdominal drainage", 
                "description": "Despite that it matches one of the cirteria as the study group:1\uff0eIntravesical pressure\u226520cmH2O or 2\uff0eCT scan:acute peripancreatic liquid collection, the patients continue acquire prearranged integrative treatment and will not accept early stage abdominal drainage until any of the followings emerge:1.Intra-abdominal apartment syndrome; 2. Pancreatic pseudocyst;3. Pancreatic or peripancreatic necrosis;", 
                "intervention_name": "Late stage abdominal drainage", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "pancreatitis", 
            "early stage", 
            "mini-invasive abdominal drainage"
        ], 
        "lastchanged_date": "December 1, 2013", 
        "location": {
            "contact": {
                "email": "chenerzhen@hotmail.com", 
                "last_name": "erzhen Chen, PhD", 
                "phone": "66370045", 
                "phone_ext": "665520"
            }, 
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "state": "Shanghai", 
                    "zip": "20000"
                }, 
                "name": "Ruijin"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effects of Early Stage Mini-invasive Abdominal Drainage on Complications and Prognosis of SAP", 
        "overall_contact": {
            "email": "chenerzhen@hotmail.com", 
            "last_name": "erzhen Chen, PhD", 
            "phone": "64370045", 
            "phone_ext": "665520"
        }, 
        "overall_contact_backup": {
            "email": "maoenqiang@hotmail.com", 
            "last_name": "enqiang Mao, PhD", 
            "phone": "64370045", 
            "phone_ext": "665520"
        }, 
        "overall_official": {
            "affiliation": "Emergency intensive care unit of Ruijin Hospital", 
            "last_name": "erzhen Chen, Professor", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Science and Technology Commission of Shanghai Municipality", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Time of first attacks of these situations that have to be surgically interfered in 28 days since onsets: ACS or pancreatic  necrosis, abdominal hemorrhage, pancreatic abscess or pancreatic pseudocyst which brings symptoms or complications or increase in size;rates of organs' dysfunction, abdominal infection and reuse of drainage;", 
            "measure": "Rates of ACS in 28 days since outbreaks", 
            "safety_issue": "Yes", 
            "time_frame": "28 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02002793"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ruijin Hospital", 
            "investigator_full_name": "Erzhen Chen", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Rates of mortality or organs' dysfunction; rates of complications, including: pancreatic leakage, pancreatic pseudocysts in need of surgical interfere, pancreatic abscess, bile duct stricture and pancreatic insufficiency; times of surgery, hospital stay, time in ICU and hospitalization expense;", 
            "measure": "Rates of surgical interfere, MODS or death in 6 months since outbreaks", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "source": "Ruijin Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "RenJi Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Ruijin Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}